Current Liabilities

Accrued Liabilities, Current

Amgen Accrued Liabilities, Current decreased by 10.5% to $16.58B in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2025
Last reportedQ1 2026

How to read this metric

A steady increase relative to revenue may indicate rising operational costs or changes in payment timing.

Detailed definition

These are short-term obligations for expenses that have been incurred but not yet invoiced or paid by the end of the rep...

Peer comparison

Standard across all industries for tracking short-term operational obligations.

Metric ID: current_liabilities_accrued_liabilities_current

Historical Data

2 periods
 Q4 '25Q1 '26
Value$18.52B$16.58B
QoQ Change-10.5%
Range$16.58B$18.52B

Frequently Asked Questions

What is Amgen's accrued liabilities, current?
Amgen (AMGN) reported accrued liabilities, current of $16.58B in Q1 2026.
What does accrued liabilities, current mean?
Short-term expenses that have been incurred but not yet paid.